The field of Clinical Trials and Clinical R&D is perfectly positioned to harness the benefits of IoT, Wearables and Emerging Technology.
An on-going shift towards Decentralized and Hybrid Clinical Trial models that leverage IoT connected devices and digital tools has continued to accelerate, gaining further buy-in from sponsors and patients alike.
With the ability to collect vast amounts of data, and real-world evidence providing significant advantages for invaluable patient insights, that not only optimize clinical R&D, but also support increasingly patient-centric outcomes.
However, with many moving parts, leading this transition can be very complex, costly and resource intensive.
With this in mind, the IoT Clinical Trials - Hybrid Edition will provide you with the necessary tools to develop a roadmap for managing change, embracing clinical innovation, and developing a strategy to create DCT’s, Hybrid and Digital Trial Elements that successfully integrate IoT and Emerging Technology for optimal results
Expert IoT, Clinical Trials and Technology Speakers
Robert J Boland MBA
Executive Director, Global Head - Digital Delivery & Data, Digital Technology
CSL Behring
Jonathan Bruno
Senior Project Manager, Digital Medicine & Translational Imaging
Pfizer
Michelle Crouthamel
Head Digital Science
AbbVie
Philipp D’Alfonso
Global Studies Manager, Global Product Development (PDG)
Roche
Hernando C Giraldo
Digital Lab, Innovation and Scouting
Boehringer Ingelheim
Bert Hartog
Research and Development Operations, Senior Director Clinical Innovation
The Janssen Pharmaceutical Companies of Johnson & Johnson
Peter Henstock
Machine Learning & AI Technical Lead
Pfizer
Victor Huynh, CISSP
Executive Director, Information Security & Risk Management
Abbvie
Amir Lahav
Digital Healthcare Innovation, Head of Strategic R&D
Mitsubishi Tanabe Pharmaceuticals
Frank Leu
CEO
Novapeutics LLC
Craig Lipset
Founder & Co-Chair
Decentralized Trials Research Alliance (DTRA)
Baldwin Mak
Digital Expert, Digital Transformation Centre of Excellence
Boehringer Ingelheim
Ashley Miller
Digital Designer
Boeringher Ingelheim
Smit Patel
Director of Digital Medicine
Digital Medicine Society, (DiMe)
Gergely Vertes
Medical Device Innovation Lead
UCB
Attending this event will enable you to:
- Identify emerging technology that will optimize clinical R&D and facilitate decentralized, hybrid and virtual trials
- Assess the value proposition for IoT in clinical trial innovation and develop a roadmap for successful technology implementation
- Digitally optimize your clinical trials to enhance patient recruitment, engagement, adherence, retention and experience
- Create and implement an effective data quality and analytics strategy that enhances connectivity, facilitates timely interventions and drives positive outcomes
- Manage the mindset and culture shift required for digital empowerment and enable a successful transition towards decentralized clinical trials
- Align your strategy with the evolving vendor landscape to create strong partnership-driven relationships with solutions provider
Who You Will Meet
VPs, Directors, Heads, Managers from:
- Decentralized Clinical Trials
- Hybrid & Virtual Clinical Trials
- Clinical Operations / R&D Operations
- Clinical Development
- Clinical Trial Innovation
- Outsource Clinical Trials
- Healthcare Innovation / Healthcare Intelligence
- Digital Health / Digital Medicine
- Patient Engagement / Patient Outcomes - Patient Affairs
- Regulatory / Clinical Affairs
Our sponsors include technology, service and solution providers specializing in:
- ePRO / Electronic patient-reported outcome
- eCOA / Electronic Clinical Outcome Assessment
- eSource / Electronic Source Data Capture / DDC Direct Data Capture
- eConsent / Digital Enrollment
- Data Analytics Software & Platforms
- Patient Experience Management Platforms / Mobile & Web Applications
- Wearables / Biosensors
- AI (Artificial Intelligence) / ML (Machine Learning
2022 Sponsors
SPONSORS
